½ÃÀ庸°í¼­
»óǰÄÚµå
1591794

Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå : Á¦Ç°, ±¸¼º, Àç·á, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Hemodialysis Catheters Market by Product (Cuffed Tunneled, Non-cuffed Tunneled, Non-Tunneled), Configuration (Split-Tip Catheters, Step-Tip Catheters, Symmetric Catheters), Material, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀåÀº 2023³â¿¡ 6¾ï 6,839¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 7¾ï 3,842¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 10.96%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 13¾ï 8,448¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀåÀº ½ÅºÎÀü ȯÀÚÀÇ »ý¸íÀ» ±¸ÇÏ´Â Åõ¼®À» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿ªÇÒ·Î Á¤Àǵ˴ϴÙ. Ç÷¾× Åõ¼® Ä«Å×ÅÍ´Â ½ÅÀåÀÌ ÀÚ¿¬ÀûÀ¸·Î ÀÌ ±â´ÉÀ» ¼öÇàÇÒ ¼ö ¾ø´Â °æ¿ì È¿À²ÀûÀÎ Ç÷¾× Á¤È­¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. Ç÷¾× Åõ¼® Ä«Å×ÅÍ´Â ÁÖ·Î º´¿ø, Åõ¼® ¼¾ÅÍ ¹× ÀçÅÃÄ¡·á¿¡¼­ »ç¿ëµË´Ï´Ù. ¸¸¼ºÄáÆÏº´(CKD)ÀÇ À¯º´·ü Áõ°¡¿Í Àα¸ °í·ÉÈ­·Î ÀÎÇØ ±× Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ¿µÇâÀ¸·Î´Â °¨¿° À§ÇèÀ» ÁÙÀ̰í ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÏ´Â Ç×±Õ ÄÚÆÃ ¹× »ýüÀûÇÕ¼º ¼ÒÀç¿Í °°Àº Ä«Å×ÅÍ ¼³°èÀÇ ±â¼ú ¹ßÀüÀÌ ÀÖ½À´Ï´Ù. ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼úÀÇ Æí¸®¼º¿¡ ÈûÀÔ¾î ÀçÅà Åõ¼® ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀº ÁÖ¸ñÇÒ ¸¸ÇÑ ±âȸ·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Ç÷·ù °¨¿°°ú Ä«Å×ÅÍ ÆÄ¼ÕÀÇ À§Çè, ±â¼ú Çõ½Å°ú ½ÂÀÎ ÀýÂ÷¸¦ Áö¿¬½ÃŰ´Â ±î´Ù·Î¿î ±ÔÁ¦ À庮ÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¿Á¤¸Æ·ç ¹× ÀÌ½Ä µî ´ëü Åõ¼® Á¢±Ù¹ý°úÀÇ °æÀïÀº ¶Ç ´Ù¸¥ Á¦¾à ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷µéÀº ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­ÇÏ°í ³»±¸¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â ¼ÒÀ縦 Ȱ¿ëÇϰí, ¾ÈÀüÇϰí Áøº¸µÈ Ä«Å×ÅÍ ¼³°è¿¡ ´ëÇÑ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ, Çコ Å×Å© ±â¾÷°úÀÇ Á¦ÈÞ¸¦ ¸ð»öÇÏ°í ½º¸¶Æ® ¸ð´ÏÅ͸µ ±â´ÉÀ» ÅëÇÕÇÔÀ¸·Î½á °æÀï ¿ìÀ§¸¦ È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸ê±Õ ±â¼ú ¹× ȯÀÚº° ¸ÂÃãÈ­ Çõ½ÅÀº È¥ÀâÇÑ ½ÃÀå¿¡¼­ Á¦Ç° Â÷º°È­¸¦ ´õ¿í °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. º´¿ø ¹æ¹® Ƚ¼ö¸¦ ÁÙÀ̰í ÀçÅà Áø·á¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â µ¥ ÁßÁ¡À» µÎ¸é¼­ ½ÃÀåÀÇ ¼º°ÝÀº Á¡Á¡ ´õ ȯÀÚ Áß½ÉÀ¸·Î º¯È­Çϰí ÀÖ½À´Ï´Ù. À̴ ƯÈ÷ ¿ø°Ý ÀÇ·á Æ®·»µå¿¡ ºÎÇÕÇÏ´Â »ç¿ëÇϱ⠽±°í ¿¬°áµÈ ±â±â °³¹ßÀ» ÅëÇØ ±â¼ú Çõ½Å°ú »ç¾÷ ¼ºÀåÀ» À§ÇÑ À¯¸ÁÇÑ ºÐ¾ßÀÓÀ» º¸¿©ÁÝ´Ï´Ù. ÀÌ·¯ÇÑ Àü·«Àû ¼ö´Ü¿¡ ÃÊÁ¡À» ¸ÂÃß¸é ±â¾÷Àº º¹ÀâÇÑ »óȲÀ» Àß ÇìÃijª°¡°í »õ·Î¿î ½ÃÀå ±âȸ¸¦ °³Ã´ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 6¾ï 6,839¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 7¾ï 3,842¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 13¾ï 8,448¸¸ ´Þ·¯
CAGR(%) 10.96%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÅÀ庴 À¯º´ÀÚ ¼ö Áõ°¡
    • ÀÌ½Ä¿ë ½ÅÀå °ø¿©ÀÚÀÇ ºÎÁ·
    • Ç×±ÕÁ¦ ÄÚÆÃ Ç÷¾× Åõ¼® Ä«Å×ÅÍÀÇ Àα⠱޻ó½Â
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ºóÇ÷, °æ·Ã, Ç÷¾× °¨¿°, Ç÷ÀüÁõ µîÀÇ ºÎÀÛ¿ëÀÌ ÀÖÀ½.
  • ½ÃÀå ±âȸ
    • Ç÷¾× Åõ¼® Ä«Å×ÅÍÀÇ ±â¼ú ¹ßÀü
    • °¡Á¤ ³» Ç÷¾×Åõ¼®(HHD) Ä¡·á¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡
  • ½ÃÀå °úÁ¦
    • Åõ¼®Ä¡·á¿¡ ´ëÇÑ ÀÇ·áºñ º¸»ó Çѵµ Á¦ÇÑ

Porter's Five Forces : Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Ç÷¾×Åõ¼® Ä«Å×ÅÍ ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå : Á¦Ç°º°

  • Cuffed Tunneled
  • Non-cuffed Tunneled
  • Non-Tunneled

Á¦7Àå Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå : ±¸¼ºº°

  • Split-Tip Catheters
  • Step-Tip Catheters
  • Symmetric Catheters

Á¦8Àå Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå : ¼ÒÀ纰

  • Æú¸®¿ì·¹Åº
  • ½Ç¸®ÄÜ

Á¦9Àå Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Åõ¼® ¼¾ÅÍ
  • ÀçÅà Åõ¼®
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦122Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç÷¾× Åõ¼® Ä«Å×ÅÍ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Allmed Medical Products Co., Ltd.
  • AngioDynamics, Inc.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Cook Group Incorporated
  • Medical Components, Inc.
  • Medtronic PLC
  • Nikkiso Co., Ltd
  • Nipro Corporation
  • Outset Medical, Inc.
  • Toray Industries, Inc.
LSH

The Hemodialysis Catheters Market was valued at USD 668.39 million in 2023, expected to reach USD 738.42 million in 2024, and is projected to grow at a CAGR of 10.96%, to USD 1,384.48 million by 2030.

The hemodialysis catheters market is defined by its critical role in facilitating dialysis, which is a life-saving procedure for patients with renal failure. These catheters are indispensable for allowing efficient blood purification when the kidneys are unable to perform this function naturally. Hemodialysis catheters are primarily used in hospitals, dialysis centers, and for home care treatment. Their necessity stems from the growing prevalence of Chronic Kidney Disease (CKD) and an aging population, which together drive demand. Key market influences include technological advancements in catheter design, such as antimicrobial coatings and biocompatible materials that reduce infection risk and improve patient outcomes. The shift towards at-home dialysis solutions presents a notable opportunity, bolstered by the convenience of remote monitoring technologies. However, market growth is tempered by challenges such as the risk of bloodstream infections, catheter failure, and stringent regulatory hurdles that can slow innovation and approval processes. Furthermore, competition from alternative dialysis access methods, such as arteriovenous fistulas and grafts, presents additional limitations. To capitalize on potential opportunities, companies should invest in research and development of advanced and safer catheter designs, utilizing materials that minimize complications and enhance durability. Additionally, exploring partnerships with health tech firms to integrate smart monitoring capabilities could offer a competitive edge. Innovations in sterilization techniques and patient-specific customization can further differentiate products in a crowded market. The nature of the market is becoming increasingly patient-centric, with a growing emphasis on reducing hospital visits and enabling at-home care. This indicates a promising area for innovation and business growth, particularly through the development of user-friendly, connected devices that align with telehealth trends. By focusing on these strategic avenues, companies can better navigate the complex landscape and tap into emerging market opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 668.39 million
Estimated Year [2024] USD 738.42 million
Forecast Year [2030] USD 1,384.48 million
CAGR (%) 10.96%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hemodialysis Catheters Market

The Hemodialysis Catheters Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in prevalence of number of kidney diseases
    • Low availability of kidney donors for transplantation
    • Surge in popularity of antimicrobial-coated hemodialysis catheters
  • Market Restraints
    • Side effects such as anemia, cramps, risk of blood infection and thrombosis
  • Market Opportunities
    • Technological advancement in hemodialysis catheters
    • Rise in preference for home hemodialysis (HHD) treatment
  • Market Challenges
    • Limitations in medical reimbursement of dialysis procedures

Porter's Five Forces: A Strategic Tool for Navigating the Hemodialysis Catheters Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hemodialysis Catheters Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hemodialysis Catheters Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hemodialysis Catheters Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hemodialysis Catheters Market

A detailed market share analysis in the Hemodialysis Catheters Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hemodialysis Catheters Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hemodialysis Catheters Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hemodialysis Catheters Market

A strategic analysis of the Hemodialysis Catheters Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hemodialysis Catheters Market, highlighting leading vendors and their innovative profiles. These include Allmed Medical Products Co., Ltd., AngioDynamics, Inc., Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cook Group Incorporated, Medical Components, Inc., Medtronic PLC, Nikkiso Co., Ltd, Nipro Corporation, Outset Medical, Inc., and Toray Industries, Inc..

Market Segmentation & Coverage

This research report categorizes the Hemodialysis Catheters Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cuffed Tunneled, Non-cuffed Tunneled, and Non-Tunneled.
  • Based on Configuration, market is studied across Split-Tip Catheters, Step-Tip Catheters, and Symmetric Catheters.
  • Based on Material, market is studied across Polyurethane and Silicone.
  • Based on End-User, market is studied across Dialysis Centers, Home Dialysis, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in prevalence of number of kidney diseases
      • 5.1.1.2. Low availability of kidney donors for transplantation
      • 5.1.1.3. Surge in popularity of antimicrobial-coated hemodialysis catheters
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects such as anemia, cramps, risk of blood infection and thrombosis
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in hemodialysis catheters
      • 5.1.3.2. Rise in preference for home hemodialysis (HHD) treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations in medical reimbursement of dialysis procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hemodialysis Catheters Market, by Product

  • 6.1. Introduction
  • 6.2. Cuffed Tunneled
  • 6.3. Non-cuffed Tunneled
  • 6.4. Non-Tunneled

7. Hemodialysis Catheters Market, by Configuration

  • 7.1. Introduction
  • 7.2. Split-Tip Catheters
  • 7.3. Step-Tip Catheters
  • 7.4. Symmetric Catheters

8. Hemodialysis Catheters Market, by Material

  • 8.1. Introduction
  • 8.2. Polyurethane
  • 8.3. Silicone

9. Hemodialysis Catheters Market, by End-User

  • 9.1. Introduction
  • 9.2. Dialysis Centers
  • 9.3. Home Dialysis
  • 9.4. Hospitals

10. Americas Hemodialysis Catheters Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Hemodialysis Catheters Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Hemodialysis Catheters Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allmed Medical Products Co., Ltd.
  • 2. AngioDynamics, Inc.
  • 3. Asahi Kasei Corporation
  • 4. B. Braun Melsungen AG
  • 5. Baxter International Inc.
  • 6. Cook Group Incorporated
  • 7. Medical Components, Inc.
  • 8. Medtronic PLC
  • 9. Nikkiso Co., Ltd
  • 10. Nipro Corporation
  • 11. Outset Medical, Inc.
  • 12. Toray Industries, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦